Skip to main content
. 2022 Oct 20;13:1042060. doi: 10.3389/fendo.2022.1042060

Table 1.

Mechanism and intervention methods of ferroptosis in IVDD.

Study Induction of ferroptosis Mechanism Effects on cells Intervention method
Zhang et al. (44) Hcy to simulate the pathological condition of HHcy Promotion of methylase expression and the upregulation of the GPX4 methylation. Inducing ferroptosis in NPCs Folic acid reducing the ability of HHcy to promote IVDD
Bin et al. (45) IL-6 to simulate inflammatory condition IL-6/miR-10a-5p/IL-6R axis Inducing ferroptosis in cartilage cells Inhibiting miR-10a-5p and subsequently derepressing IL-6R signaling pathway
Lu et al. (71) TBHP to simulate oxidative stress condition FPN downregulation and intercellular iron overload Inducing ferroptosis in NPCs. Enhancing the nuclear translocation of MTF1 by suppressing the JNK pathway and ameliorating the progression of IVDD
Shan et al. (31) Heme to simulate neovascularization condition Increased heme catabolism, downregulation of GPX4, and intercellular iron overload, which might be mediated by the Notch pathway Inducing ferroptosis in NPCs. Inhibiting of the Notch signaling pathway
Yang et al. (72) TBHP to simulate oxidative stress condition NCOA4-mediated ferritinophagy and intercellular iron overload Inducing ferroptosis in NPCs and AFCs. Silencing NCOA4 to alleviate ferroptosis
Li et al. (114) TBHP to simulate oxidative stress condition Upregulation of ATF3 and ROS products Inducing ferroptosis in NPCs. Silencing ATF3 by miR-874-3p and alleviating IVDD
Wang et al. (115) FAC to simulate iron overload condition Mineralization of endplate chondrocytes and oxidative stress Inducing ferroptosis in endplate chondrocytes. DFO, NAC and ferrostatin-1 rescuing high dose iron-induced IVDD and cartilage endplate calcification
Yu et al. (116) IL-1β to simulate inflammatory condition Decreased NRF2 expression and upregulation of ROS products Inducing ferroptosis in NPCs. circ_0072464 shuttled by BMSC-secreted EVs inhibiting NPC ferroptosis by downregulation of miR-431 and upregulation of NRF2.

IVDD, Intervertebral disc degeneration; Hcy, homocysteine; HHcy, hyperhomocysteinemia; NPCs, nucleus pulposus cells; TBHP, tert-butyl hydroperoxide; FPN, ferroportin; MTF1, metal-regulatory transcription factor 1; GPX4, glutathione peroxidase 4; NCOA4, nuclear receptor coactivator 4; AFCs, annulus fibrosus cells; ATF3, activation transcription factor 3; ROS, reactive oxygen species; FAC, ferric ammonium citrate; DFO, deferoxamine; NAC, N-acetyl-cysteine; NRF2, nuclear factor-erythroid 2 like 2; BMSC, bone marrow mesenchymal stem cells; EV, extracellular vesicle.